ANI Pharmaceuticals, Inc. (ANIP) vs Perrigo Company plc (PRGO)
ANI Pharmaceuticals, Inc. and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.1B against $1.7B — 1.2× the size. Perrigo Company plc has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 15.3×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 30.9% against −4.19%. ANI Pharmaceuticals, Inc. has the higher net margin (11.0% vs −41.9%) and the higher return on invested capital (11.3% vs −18.1%). Across the 19 metrics below, ANI Pharmaceuticals, Inc. leads on 15 and Perrigo Company plc on 4.
Valuation
Profitability
| Metric | ANIP | PRGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.40% | 33.26% | 53.94% |
| Operating margin | 15.37% | (37.71%) | 0.00% |
| Net margin | 11.04% | (41.85%) | 0.00% |
| Free cash flow margin | 17.12% | 2.88% | 0.00% |
| Return on equity | 20.88% | (49.65%) | (0.40%) |
| Return on assets | 7.61% | (19.60%) | (3.32%) |
| Return on invested capital | 11.30% | (18.06%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack